We are live on
!
Find out more
KCM
KRS Capital Management Portfolio holdings
AUM
$215M
1-Year Est. Return
69.3%
This Fund
S&P 500
This Quarter
Est. Return
-3.53%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.8M
AUM Growth
-$6.23M
(-6.2%)
Cap. Flow
-$257K
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
43.99%
Holding
117
New
5
Increased
47
Reduced
35
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.45M |
| 2 |
Cadence Design Systems
CDNS
|
+$366K |
| 3 |
Oracle
ORCL
|
+$347K |
| 4 |
Carrier Global
CARR
|
+$290K |
| 5 |
Parker-Hannifin
PH
|
+$246K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$2.85M |
| 2 |
Walt Disney
DIS
|
+$242K |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$228K |
| 4 |
PayPal
PYPL
|
+$227K |
| 5 |
Dollar General
DG
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.13% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 7.64% |
| 4 | Financials | 7.3% |
| 5 | Industrials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
76
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $324K | 0.34% |
1,914
+205
| +12% | +$38.5K |
|
77
Southern Company
SO
$107B
| $317K | 0.34% |
4,896
-139
| -3% | -$9.65K |
|
78
Intuitive Surgical
ISRG
$134B
| $316K | 0.34% |
1,080
+408
| +61% | +$127K |
|
79
iShares Russell 2000 ETF
IWM
$82.7B
| $313K | 0.33% |
1,770
-140
| -7% | -$26.3K |
|
|
80
Carrier Global
CARR
$52.8B
| $291K | 0.31% |
+5,272
| New | +$290K |
|
81
Target
TGT
$67.1B
| $286K | 0.31% |
2,589
-258
| -9% | -$32.8K |
|
82
Enbridge
ENB
$112B
| $283K | 0.3% |
8,443
+2,450
| +41% | +$87K |
|
|
XYZ
83
Block Inc
XYZ
$47.9B
| $283K | 0.3% |
6,389
-3,205
| -33% | -$198K |
|
84
Shopify
SHOP
$196B
| $277K | 0.3% |
5,080
-400
| -7% | -$24.2K |
|
85
RTX Corp
RTX
$298B
| $274K | 0.29% |
3,809
-500
| -12% | -$42.8K |
|
86
Regeneron Pharmaceuticals
REGN
$80B
| $272K | 0.29% |
330
-15
| -4% | -$11.8K |
|
87
InMode
INMD
$874M
| $268K | 0.29% |
8,784
+1,975
| +29% | +$77.5K |
|
88
Workday
WDAY
$44.9B
| $265K | 0.28% |
1,235
| – | – |
|
89
FedEx
FDX
$74.9B
| $265K | 0.28% |
1,000
+1
| +0.1% | +$260 |
|
90
Kinder Morgan
KMI
$68.7B
| $260K | 0.28% |
15,684
+1,490
| +10% | +$25.7K |
|
91
Autoliv
ALV
$9.04B
| $259K | 0.28% |
2,688
| – | – |
|
92
Coca-Cola
KO
$373B
| $251K | 0.27% |
4,475
+10
| +0.2% | +$600 |
|
93
Edwards Lifesciences
EW
$51.9B
| $248K | 0.26% |
3,580
-345
| -9% | -$27.7K |
|
94
Huntington Bancshares
HBAN
$35.2B
| $245K | 0.26% |
23,592
-15,436
| -40% | -$173K |
|
95
Dollar Tree
DLTR
$24.9B
| $241K | 0.26% |
2,265
-620
| -21% | -$83.1K |
|
|
96
Parker-Hannifin
PH
$137B
| $238K | 0.25% |
+611
| New | +$246K |
|
97
Intercontinental Exchange
ICE
$86B
| $234K | 0.25% |
2,130
| – | – |
|
98
Airbnb
ABNB
$104B
| $234K | 0.25% |
1,706
-115
| -6% | -$15.9K |
|
99
IBM
IBM
$223B
| $233K | 0.25% |
1,661
-2
| -0.1% | -$285 |
|
|
EA
100
DELISTED
Electronic Arts
EA
| $232K | 0.25% |
1,930
| – | – |
|
Similar funds
VFG
IAM
VEA
RC
NCM
TSS
CMBA
IH
KRS Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, KRS Capital Management held 117 positions worth $93.8M, down 6.2% from $100M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
KRS Capital Management's Q3 2023 filing shows 5 new, 47 increased, 35 reduced and 6 closed positions. Its largest new stake was Cadence Design Systems: 1,562 shares worth $366K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.85M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- KRS Capital Management's largest Q3 2023 buy was Cadence Design Systems: 1,562 shares worth $366K.
- KRS Capital Management added most to Bank of America in Q3 2023, an estimated $1.45M increase.
- KRS Capital Management's biggest Q3 2023 reduction was Walt Disney, cutting an estimated $242K.
- KRS Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.85M.
- KRS Capital Management's ten largest holdings make up 44% of its $93.8M portfolio in Q3 2023.
- KRS Capital Management opened 5 new positions and closed 6 in Q3 2023.
- KRS Capital Management's portfolio value fell 6.2% quarter-over-quarter to $93.8M.
Based on KRS Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.